drug

FG-3246

1 story · latest Aug 13, 2026

Status: Investigational
Code: FOR46
Trials: 1 registered trial in coverage

Relationships

Developed by Kyntra Bio

Timeline

Kyntra Bio reports Q2 2026 results, reaffirms fourth-quarter trial milestones

Aug 13Quarterly updateFG-3246 Kyntra Bio

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.